
Rebless 20mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Rivaroxaban (20mg)
Overview Rebless 20mg Tablet
CardioGuard 20mg tablets function as an anticoagulant, preventing and treating blood clots to mitigate stroke and heart attack risk. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent thrombosis, it also lowers clot risk post-knee or hip replacement. It can be administered with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications such as quitting smoking, healthy eating, regular exercise, and weight management further reduce clot risk. Increased bleeding tendency (e.g., nosebleeds, bruising) is a common side effect; report any unusual symptoms immediately. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't necessary.
Primary Ingredients of Rebless 20mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Rebless 20mg Tablet
Managing and preventing venous thromboembolism
Major Benefits of Rebless 20mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rebless 20mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Rebless 20mg Tablet:
- Bleeding
How to use Rebless 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the 20mg Rebless Tablet whole; do not crush, chew, or break it. While you can take it with or without food, consistency is key—take it at the same time each day.
How Rebless 20mg Tablet works:
Xaclotting 20mg tablets represent a new class of oral blood thinners. Their mechanism of action involves the inhibition of factor Xa, a key component in blood clot formation, thus reducing the risk of thrombosis.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Rebless 20mg tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rebless 20mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rebless 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rebless 20mg Tablets, which can induce dizziness or loss of consciousness. Side effects from Rebless 20mg Tablets may impact your capacity to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use Rebless 20mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Reblass 20mg Tablets are contraindicated for individuals with severe kidney disease.
LiverUNSAFE
The use of Rebless 20mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice.
What if you forget to take Rebless 20mg Tablet :
Should you forget a Rebless 20mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebless 20mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine- and thiophene-based derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Xa Inhibitors for Oral Administration |
